speb/financial-data huggingface dataset:
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 7543563.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: 234435000.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 49822000.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: 1244474000.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 4338000.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Other Inventories: 325000.00
RELCHEMQ.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: 83478000.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: 97932000.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Other Non Current Liabilities: -1000.00
RELCHEMQ.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 945000.00
RELCHEMQ.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 405502000.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Other Payable: 156021000.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Other Properties: 1934993000.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 50744000.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 572713000.00
RELCHEMQ.NS income_statement (annual, 2023-03-31) — Other Special Charges: 2673000.00
RELCHEMQ.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Payables: 301991000.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 9298000.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 268437000.00
RELCHEMQ.NS income_statement (annual, 2023-03-31) — Pretax Income: 167075000.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
RELCHEMQ.NS cash_flow (annual, 2023-03-31) — Provisionand Write Offof Assets: 0.00
RELCHEMQ.NS cash_flow (annual, 2023-03-31) — Purchase Of Investment: 0.00
RELCHEMQ.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -545738000.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Raw Materials: 198982000.00
RELCHEMQ.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 2000544000.00
RELCHEMQ.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 97569000.00
RELCHEMQ.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 510000.00
RELCHEMQ.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 510000.00
RELCHEMQ.NS cash_flow (annual, 2023-03-31) — Repayment Of Debt: 0.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Restricted Cash: 2247000.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: 923799000.00
RELCHEMQ.NS cash_flow (annual, 2023-03-31) — Sale Of Investment: 2358000.00
RELCHEMQ.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 5461000.00
RELCHEMQ.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 349164000.00
RELCHEMQ.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 355911000.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Share Issued: 7543563.00
RELCHEMQ.NS cash_flow (annual, 2023-03-31) — Short Term Debt Issuance: 521650000.00
RELCHEMQ.NS cash_flow (annual, 2023-03-31) — Short Term Debt Payments: 0.00
RELCHEMQ.NS income_statement (annual, 2023-03-31) — Special Income Charges: -2673000.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 1320071000.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 1315733000.00
RELCHEMQ.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: -172225.01
RELCHEMQ.NS income_statement (annual, 2023-03-31) — Tax Provision: 42883000.00
RELCHEMQ.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.26
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Taxes Receivable: 19125000.00
RELCHEMQ.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -25650000.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Total Assets: 3969612000.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 1984056000.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Total Debt: 1993458000.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 1320071000.00
RELCHEMQ.NS income_statement (annual, 2023-03-31) — Total Expenses: 3295187000.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 2649541000.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 2508280000.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 995138000.00
RELCHEMQ.NS income_statement (annual, 2023-03-31) — Total Other Finance Cost: 54097000.00
RELCHEMQ.NS income_statement (annual, 2023-03-31) — Total Unusual Items: -671000.00
RELCHEMQ.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: -671000.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Tradeand Other Payables Non Current: 22003000.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Work In Process: 107397000.00
RELCHEMQ.NS balance_sheet (annual, 2023-03-31) — Working Capital: -193074000.00
RELCHEMQ.NS income_statement (annual, 2024-03-31) — +Operating Expense: 1373809000.00
RELCHEMQ.NS income_statement (annual, 2024-03-31) — +Total Revenue: 3559555000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 167419000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 61464000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -470626000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 256196000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: -845000.00
RELCHEMQ.NS cash_flow (annual, 2024-03-31) — Amortization Cash Flow: 184000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 830000.00
RELCHEMQ.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 7543563.00
RELCHEMQ.NS income_statement (annual, 2024-03-31) — Basic EPS: 4.26
RELCHEMQ.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 40436000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 778490000.00
RELCHEMQ.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -925998000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 22270000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 75597000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 2719000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 503782000.00
RELCHEMQ.NS cash_flow (annual, 2024-03-31) — Cash Dividends Paid: -18859000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Cash Equivalents: 0.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 2719000.00
RELCHEMQ.NS cash_flow (annual, 2024-03-31) — Change In Inventory: -85811000.00
RELCHEMQ.NS cash_flow (annual, 2024-03-31) — Change In Other Current Assets: -35942000.00
RELCHEMQ.NS cash_flow (annual, 2024-03-31) — Change In Other Current Liabilities: -39957000.00
RELCHEMQ.NS cash_flow (annual, 2024-03-31) — Change In Payable: 23968000.00
RELCHEMQ.NS cash_flow (annual, 2024-03-31) — Change In Receivables: 12592000.00
RELCHEMQ.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: -120381000.00
RELCHEMQ.NS cash_flow (annual, 2024-03-31) — Changes In Cash: -37717000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Common Stock: 75597000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 1336492000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 8042000.00
RELCHEMQ.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 1995631000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Current Assets: 1563337000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 8680000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Current Debt: 1283583000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 1292263000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 1637841000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Current Provisions: 14082000.00
RELCHEMQ.NS cash_flow (annual, 2024-03-31) — Depreciation: 101261000.00
RELCHEMQ.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 101261000.00
RELCHEMQ.NS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 101261000.00
RELCHEMQ.NS income_statement (annual, 2024-03-31) — Depreciation Income Statement: 101261000.00
RELCHEMQ.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 7543563.00
RELCHEMQ.NS income_statement (annual, 2024-03-31) — Diluted EPS: 4.26
RELCHEMQ.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 32099000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Dividends Payable: 2109000.00
RELCHEMQ.NS income_statement (annual, 2024-03-31) — EBIT: 174568000.00
RELCHEMQ.NS income_statement (annual, 2024-03-31) — EBITDA: 275829000.00
RELCHEMQ.NS cash_flow (annual, 2024-03-31) — End Cash Position: 2719000.00
RELCHEMQ.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: 598097000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Finished Goods: 179154000.00
RELCHEMQ.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: -746493000.00
RELCHEMQ.NS cash_flow (annual, 2024-03-31) — Gain Loss On Investment Securities: -2203000.00
RELCHEMQ.NS cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of PPE: -56000.00
RELCHEMQ.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 7811000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 6248000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 62309000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 3628907000.00
RELCHEMQ.NS income_statement (annual, 2024-03-31) — Gross Profit: 1563924000.00
RELCHEMQ.NS income_statement (annual, 2024-03-31) — Interest Expense: 118293000.00
RELCHEMQ.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 118293000.00
RELCHEMQ.NS income_statement (annual, 2024-03-31) — Interest Income: 38698000.00
RELCHEMQ.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 38698000.00
RELCHEMQ.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -196430000.00
RELCHEMQ.NS cash_flow (annual, 2024-03-31) — Interest Received Cfi: 38772000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Inventory: 538507000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 4124090000.00
RELCHEMQ.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: -815319000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Investment Properties: 19593000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 830000.00
RELCHEMQ.NS cash_flow (annual, 2024-03-31) — Issuance Of Debt: 840029000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 410522000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 13590000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Long Term Debt: 1504015000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 1517605000.00
RELCHEMQ.NS cash_flow (annual, 2024-03-31) — Long Term Debt Issuance: 840029000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Long Term Provisions: 4743000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 2431853000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Net Debt: 2784879000.00
RELCHEMQ.NS income_statement (annual, 2024-03-31) — Net Income: 32099000.00
RELCHEMQ.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 32099000.00
RELCHEMQ.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 32099000.00
RELCHEMQ.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 32099000.00
RELCHEMQ.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 32099000.00
RELCHEMQ.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 56275000.00
RELCHEMQ.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 32099000.00
RELCHEMQ.NS income_statement (annual, 2024-03-31) — Net Interest Income: -156956000.00
RELCHEMQ.NS cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: 71787000.00
RELCHEMQ.NS cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: 825043000.00
RELCHEMQ.NS cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: 840029000.00
RELCHEMQ.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: -156956000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Net PPE: 3158281000.00
RELCHEMQ.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -925878000.00
RELCHEMQ.NS cash_flow (annual, 2024-03-31) — Net Short Term Debt Issuance: -14986000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 1330244000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Liabilities: 288204000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 4743000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 61971000.00
RELCHEMQ.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 273570000.00
RELCHEMQ.NS income_statement (annual, 2024-03-31) — Normalized Income: 30517700.00
RELCHEMQ.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: 179505000.00
RELCHEMQ.NS income_statement (annual, 2024-03-31) — Operating Income: 190115000.00
RELCHEMQ.NS income_statement (annual, 2024-03-31) — Operating Revenue: 3559555000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 7543563.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: 378155000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 28940000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: 1260895000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 6248000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Other Inventories: 1098000.00
RELCHEMQ.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: 156327000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: 5021000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Other Non Current Liabilities: 670000.00
RELCHEMQ.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 1079000.00
RELCHEMQ.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 507114000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Other Payable: 144093000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Other Properties: 3150240000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 43416000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 501063000.00
RELCHEMQ.NS income_statement (annual, 2024-03-31) — Other Special Charges: -56000.00
RELCHEMQ.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Payables: 313621000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 14082000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 414059000.00
RELCHEMQ.NS income_statement (annual, 2024-03-31) — Pretax Income: 56275000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Properties: 0.00
RELCHEMQ.NS cash_flow (annual, 2024-03-31) — Purchase Of Investment: 0.00
RELCHEMQ.NS cash_flow (annual, 2024-03-31) — Purchase Of PPE: -925998000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Raw Materials: 201417000.00
RELCHEMQ.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 1995631000.00
RELCHEMQ.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 101261000.00
RELCHEMQ.NS income_statement (annual, 2024-03-31) — Rent And Landing Fees: 2020000.00
RELCHEMQ.NS income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 2020000.00
RELCHEMQ.NS cash_flow (annual, 2024-03-31) — Repayment Of Debt: -14986000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Restricted Cash: 2109000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: 940220000.00
RELCHEMQ.NS cash_flow (annual, 2024-03-31) — Sale Of Investment: 71787000.00
RELCHEMQ.NS cash_flow (annual, 2024-03-31) — Sale Of PPE: 120000.00
RELCHEMQ.NS income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 268667000.00
RELCHEMQ.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 276478000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Share Issued: 7543563.00
RELCHEMQ.NS cash_flow (annual, 2024-03-31) — Short Term Debt Issuance: 0.00
RELCHEMQ.NS cash_flow (annual, 2024-03-31) — Short Term Debt Payments: -14986000.00
RELCHEMQ.NS income_statement (annual, 2024-03-31) — Special Income Charges: 56000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 1336492000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 1330244000.00
RELCHEMQ.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 677700.00
RELCHEMQ.NS income_statement (annual, 2024-03-31) — Tax Provision: 24176000.00
RELCHEMQ.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.30
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Taxes Receivable: 21851000.00
RELCHEMQ.NS cash_flow (annual, 2024-03-31) — Taxes Refund Paid: -11718000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Total Assets: 4810260000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 2840507000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Total Debt: 2809868000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 1336492000.00
RELCHEMQ.NS income_statement (annual, 2024-03-31) — Total Expenses: 3369440000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 3473768000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 3246923000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 1835927000.00
RELCHEMQ.NS income_statement (annual, 2024-03-31) — Total Other Finance Cost: 77361000.00
RELCHEMQ.NS income_statement (annual, 2024-03-31) — Total Unusual Items: 2259000.00
RELCHEMQ.NS income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: 2259000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Tradeand Other Payables Non Current: 21646000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Treasury Shares Number: 0.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Work In Process: 156838000.00
RELCHEMQ.NS balance_sheet (annual, 2024-03-31) — Working Capital: -74504000.00
RELCHEMQ.NS balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 245645000.00
RELCHEMQ.NS balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 143205000.00
RELCHEMQ.NS balance_sheet (quarterly, 2024-09-30) — Available For Sale Securities: 63036000.00
RELCHEMQ.NS income_statement (quarterly, 2024-09-30) — Basic Average Shares: 7535979.00
RELCHEMQ.NS income_statement (quarterly, 2024-09-30) — Basic EPS: 1.89
RELCHEMQ.NS balance_sheet (quarterly, 2024-09-30) — Capital Lease Obligations: 17768000.00
RELCHEMQ.NS balance_sheet (quarterly, 2024-09-30) — Capital Stock: 75597000.00
RELCHEMQ.NS balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 1991000.00
RELCHEMQ.NS balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 298134000.00
RELCHEMQ.NS balance_sheet (quarterly, 2024-09-30) — Common Stock: 75597000.00
RELCHEMQ.NS balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 1350659000.00
RELCHEMQ.NS balance_sheet (quarterly, 2024-09-30) — Construction In Progress: 42008000.00
RELCHEMQ.NS balance_sheet (quarterly, 2024-09-30) — Current Assets: 1499803000.00
RELCHEMQ.NS balance_sheet (quarterly, 2024-09-30) — Current Capital Lease Obligation: 12643000.00
RELCHEMQ.NS balance_sheet (quarterly, 2024-09-30) — Current Debt: 1155646000.00
RELCHEMQ.NS balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 1168289000.00
RELCHEMQ.NS balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 1616698000.00
RELCHEMQ.NS balance_sheet (quarterly, 2024-09-30) — Current Provisions: 19507000.00
RELCHEMQ.NS income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 7535979.00
RELCHEMQ.NS income_statement (quarterly, 2024-09-30) — Diluted EPS: 1.89
RELCHEMQ.NS balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 5596000.00
RELCHEMQ.NS balance_sheet (quarterly, 2024-09-30) — Gross PPE: 3158967000.00
RELCHEMQ.NS balance_sheet (quarterly, 2024-09-30) — Inventory: 594512000.00
RELCHEMQ.NS balance_sheet (quarterly, 2024-09-30) — Invested Capital: 3999998000.00
RELCHEMQ.NS balance_sheet (quarterly, 2024-09-30) — Investment Properties: 19594000.00
RELCHEMQ.NS balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 63036000.00
RELCHEMQ.NS balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 5125000.00
RELCHEMQ.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt: 1493693000.00
RELCHEMQ.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 1498818000.00
RELCHEMQ.NS balance_sheet (quarterly, 2024-09-30) — Long Term Provisions: 4743000.00
RELCHEMQ.NS balance_sheet (quarterly, 2024-09-30) — Net Debt: 2647348000.00
RELCHEMQ.NS balance_sheet (quarterly, 2024-09-30) — Net PPE: 3158967000.00
RELCHEMQ.NS balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 1345063000.00
RELCHEMQ.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Liabilities: 273744000.00
RELCHEMQ.NS balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 7543563.00
RELCHEMQ.NS balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 440284000.00
RELCHEMQ.NS balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 3213000.00
RELCHEMQ.NS balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: 1275062000.00
RELCHEMQ.NS balance_sheet (quarterly, 2024-09-30) — Other Intangible Assets: 5596000.00
RELCHEMQ.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Assets: 1281000.00
RELCHEMQ.NS balance_sheet (quarterly, 2024-09-30) — Other Properties: 3116959000.00
RELCHEMQ.NS balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 296143000.00
RELCHEMQ.NS balance_sheet (quarterly, 2024-09-30) — Payables: 245645000.00
RELCHEMQ.NS balance_sheet (quarterly, 2024-09-30) — Share Issued: 7543563.00
RELCHEMQ.NS balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 1350659000.00
RELCHEMQ.NS balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 1345063000.00
RELCHEMQ.NS balance_sheet (quarterly, 2024-09-30) — Taxes Receivable: 23668000.00
RELCHEMQ.NS balance_sheet (quarterly, 2024-09-30) — Total Assets: 4748277000.00
RELCHEMQ.NS balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 2844352000.00
RELCHEMQ.NS balance_sheet (quarterly, 2024-09-30) — Total Debt: 2667107000.00
RELCHEMQ.NS balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 1350659000.00
RELCHEMQ.NS balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 3397618000.00
RELCHEMQ.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 3248474000.00
RELCHEMQ.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 1780920000.00
RELCHEMQ.NS balance_sheet (quarterly, 2024-09-30) — Working Capital: -116895000.00
RELCHEMQ.NS income_statement (quarterly, 2024-12-31) — +Operating Expense: 302662000.00
RELCHEMQ.NS income_statement (quarterly, 2024-12-31) — +Total Revenue: 922298000.00
RELCHEMQ.NS income_statement (quarterly, 2024-12-31) — Basic Average Shares: 7426923.00
RELCHEMQ.NS income_statement (quarterly, 2024-12-31) — Basic EPS: 0.26
RELCHEMQ.NS income_statement (quarterly, 2024-12-31) — Cost Of Revenue: 565026000.00
RELCHEMQ.NS income_statement (quarterly, 2024-12-31) — Depreciation And Amortization In Income Statement: 35032000.00
RELCHEMQ.NS income_statement (quarterly, 2024-12-31) — Depreciation Income Statement: 35032000.00
RELCHEMQ.NS income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 7426923.00
RELCHEMQ.NS income_statement (quarterly, 2024-12-31) — Diluted EPS: 0.26
RELCHEMQ.NS income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: 1931000.00
RELCHEMQ.NS income_statement (quarterly, 2024-12-31) — EBIT: 60234000.00
RELCHEMQ.NS income_statement (quarterly, 2024-12-31) — EBITDA: 95266000.00
RELCHEMQ.NS income_statement (quarterly, 2024-12-31) — Gross Profit: 357272000.00
RELCHEMQ.NS income_statement (quarterly, 2024-12-31) — Interest Expense: 59060000.00
RELCHEMQ.NS income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 59060000.00
RELCHEMQ.NS income_statement (quarterly, 2024-12-31) — Net Income: 1931000.00
RELCHEMQ.NS income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: 1931000.00
RELCHEMQ.NS income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: 1931000.00
RELCHEMQ.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 1931000.00
RELCHEMQ.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 1931000.00
RELCHEMQ.NS income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: 1931000.00
RELCHEMQ.NS income_statement (quarterly, 2024-12-31) — Net Interest Income: -59060000.00
RELCHEMQ.NS income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: -59060000.00
RELCHEMQ.NS income_statement (quarterly, 2024-12-31) — Normalized EBITDA: 95266000.00
RELCHEMQ.NS income_statement (quarterly, 2024-12-31) — Normalized Income: 1931000.00
RELCHEMQ.NS income_statement (quarterly, 2024-12-31) — Operating Income: 54610000.00
RELCHEMQ.NS income_statement (quarterly, 2024-12-31) — Operating Revenue: 922298000.00
RELCHEMQ.NS income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: 5624000.00
RELCHEMQ.NS income_statement (quarterly, 2024-12-31) — Other Operating Expenses: 107547000.00
RELCHEMQ.NS income_statement (quarterly, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
RELCHEMQ.NS income_statement (quarterly, 2024-12-31) — Pretax Income: 1174000.00
RELCHEMQ.NS income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 565026000.00
RELCHEMQ.NS income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 35032000.00
RELCHEMQ.NS income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
RELCHEMQ.NS income_statement (quarterly, 2024-12-31) — Tax Provision: -757000.00
RELCHEMQ.NS income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.30
RELCHEMQ.NS income_statement (quarterly, 2024-12-31) — Total Expenses: 867688000.00
RELCHEMQ.NS income_statement (annual, 2025-03-31) — +Operating Expense: 1667649000.00
RELCHEMQ.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 425801000.00
RELCHEMQ.NS income_statement (annual, 2025-03-31) — +Total Revenue: 3585978000.00
RELCHEMQ.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 822026000.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 275684000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 275684000.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 175504000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 175504000.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -591686000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -591686000.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 256196000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 256196000.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -845000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -845000.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 20454000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 20454000.00
RELCHEMQ.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 7547015.00
RELCHEMQ.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 7541803.00
RELCHEMQ.NS income_statement (annual, 2025-03-31) — Basic EPS: 5.36
RELCHEMQ.NS income_statement (quarterly, 2025-03-31) — Basic EPS: 2.44
RELCHEMQ.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 2719000.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 796583000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 796583000.00
RELCHEMQ.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -90101000.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 16418000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 16418000.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 75597000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 75597000.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 5799000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 5799000.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 112271000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 112271000.00
RELCHEMQ.NS cash_flow (annual, 2025-03-31) — Cash Dividends Paid: -7544000.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Cash Equivalents: 3700000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 3700000.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 2099000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 2099000.00
RELCHEMQ.NS cash_flow (annual, 2025-03-31) — Change In Inventory: -153017000.00
RELCHEMQ.NS cash_flow (annual, 2025-03-31) — Change In Other Current Assets: -119824000.00
RELCHEMQ.NS cash_flow (annual, 2025-03-31) — Change In Other Current Liabilities: -3876000.00
RELCHEMQ.NS cash_flow (annual, 2025-03-31) — Change In Payable: 132599000.00
RELCHEMQ.NS cash_flow (annual, 2025-03-31) — Change In Receivables: -114441000.00
RELCHEMQ.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: -251107000.00
RELCHEMQ.NS cash_flow (annual, 2025-03-31) — Changes In Cash: 3080000.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Common Stock: 75597000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 75597000.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 1372831000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 1372831000.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 0.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 0.00
RELCHEMQ.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 1742350000.00
RELCHEMQ.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 324869000.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Current Assets: 1531268000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 1531268000.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 9390000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 9390000.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Current Debt: 1215003000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Current Debt: 1215003000.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 1224393000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 1224393000.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 1679503000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 1679503000.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 10474000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 10474000.00
RELCHEMQ.NS cash_flow (annual, 2025-03-31) — Depreciation: 146673000.00
RELCHEMQ.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 146673000.00
RELCHEMQ.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 146673000.00
RELCHEMQ.NS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 42233000.00
RELCHEMQ.NS income_statement (annual, 2025-03-31) — Depreciation Income Statement: 146673000.00
RELCHEMQ.NS income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 42233000.00
RELCHEMQ.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 7547015.00
RELCHEMQ.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 7541803.00
RELCHEMQ.NS income_statement (annual, 2025-03-31) — Diluted EPS: 5.36
RELCHEMQ.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: 2.44
RELCHEMQ.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 40452000.00
RELCHEMQ.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 18402000.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Dividends Payable: 1744000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Dividends Payable: 1744000.00
RELCHEMQ.NS income_statement (annual, 2025-03-31) — EBIT: 277672000.00
RELCHEMQ.NS income_statement (quarterly, 2025-03-31) — EBIT: 88583000.00
RELCHEMQ.NS income_statement (annual, 2025-03-31) — EBITDA: 424345000.00
RELCHEMQ.NS income_statement (quarterly, 2025-03-31) — EBITDA: 130816000.00
RELCHEMQ.NS cash_flow (annual, 2025-03-31) — End Cash Position: 5799000.00
RELCHEMQ.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: -433836000.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Finished Goods: 187625000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Finished Goods: 187625000.00
RELCHEMQ.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: 17995000.00
RELCHEMQ.NS cash_flow (annual, 2025-03-31) — Gain Loss On Investment Securities: -3354000.00
RELCHEMQ.NS cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of PPE: -226000.00
RELCHEMQ.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 8979000.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 5017000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 5017000.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 176349000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 176349000.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 3694766000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 3694766000.00
RELCHEMQ.NS income_statement (annual, 2025-03-31) — Gross Profit: 1843628000.00
RELCHEMQ.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 497157000.00
RELCHEMQ.NS income_statement (annual, 2025-03-31) — Interest Expense: 241103000.00
RELCHEMQ.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 58293000.00
RELCHEMQ.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 241103000.00
RELCHEMQ.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 58293000.00
RELCHEMQ.NS income_statement (annual, 2025-03-31) — Interest Income: 21232000.00
RELCHEMQ.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 21232000.00
RELCHEMQ.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -239917000.00
RELCHEMQ.NS cash_flow (annual, 2025-03-31) — Interest Received Cfi: 23400000.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Inventory: 691524000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Inventory: 691524000.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 3984244000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 3984244000.00
RELCHEMQ.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: 328820000.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Investment Properties: 19224000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Investment Properties: 19224000.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 20454000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 20454000.00
RELCHEMQ.NS cash_flow (annual, 2025-03-31) — Issuance Of Debt: 0.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Land And Improvements: 404014000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 404014000.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Long Term Capital Lease Obligation: 7028000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 7028000.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Long Term Debt: 1396410000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 1396410000.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 1403438000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 1403438000.00
RELCHEMQ.NS cash_flow (annual, 2025-03-31) — Long Term Debt Payments: -107604000.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Long Term Provisions: 11050000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 11050000.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 2494169000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 2494169000.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Net Debt: 2605614000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Net Debt: 2605614000.00
RELCHEMQ.NS income_statement (annual, 2025-03-31) — Net Income: 40452000.00
RELCHEMQ.NS income_statement (quarterly, 2025-03-31) — Net Income: 18402000.00
RELCHEMQ.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 40452000.00
RELCHEMQ.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 18402000.00
RELCHEMQ.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 40452000.00
RELCHEMQ.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 18402000.00
RELCHEMQ.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 40452000.00
RELCHEMQ.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 18402000.00
RELCHEMQ.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 40452000.00
RELCHEMQ.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 18402000.00
RELCHEMQ.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 36569000.00
RELCHEMQ.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 40452000.00
RELCHEMQ.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 18402000.00
RELCHEMQ.NS income_statement (annual, 2025-03-31) — Net Interest Income: -241103000.00
RELCHEMQ.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -58293000.00
RELCHEMQ.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: 394956000.00
RELCHEMQ.NS cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: -176184000.00
RELCHEMQ.NS cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: -107604000.00
RELCHEMQ.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -241103000.00
RELCHEMQ.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -58293000.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Net PPE: 3103080000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 3103080000.00
RELCHEMQ.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -89536000.00
RELCHEMQ.NS cash_flow (annual, 2025-03-31) — Net Short Term Debt Issuance: -68580000.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 1367814000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 1367814000.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Liabilities: 275936000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 275936000.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 11050000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 11050000.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 64546000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 64546000.00
RELCHEMQ.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: 424345000.00
RELCHEMQ.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 130816000.00
RELCHEMQ.NS income_statement (annual, 2025-03-31) — Normalized Income: 40452000.00
RELCHEMQ.NS income_statement (quarterly, 2025-03-31) — Normalized Income: 18402000.00
RELCHEMQ.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: 108096000.00
RELCHEMQ.NS income_statement (annual, 2025-03-31) — Operating Income: 175979000.00
RELCHEMQ.NS income_statement (quarterly, 2025-03-31) — Operating Income: 71356000.00
RELCHEMQ.NS income_statement (annual, 2025-03-31) — Operating Revenue: 3585978000.00
RELCHEMQ.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 822026000.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 7543563.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 7543563.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 455850000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 455850000.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 44057000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 44057000.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: 1297234000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 1297234000.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 5017000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 5017000.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Other Inventories: 562000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Other Inventories: 562000.00
RELCHEMQ.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: 219825000.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: 1270000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 1270000.00
RELCHEMQ.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 101693000.00
RELCHEMQ.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 17227000.00
RELCHEMQ.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 854006000.00
RELCHEMQ.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 213622000.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Other Payable: 132603000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 132603000.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Other Properties: 3103080000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 3103080000.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 67636000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 67636000.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 106472000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 106472000.00
RELCHEMQ.NS income_statement (annual, 2025-03-31) — Other Special Charges: -10176000.00
RELCHEMQ.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
RELCHEMQ.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Payables: 410031000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Payables: 410031000.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 10474000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 10474000.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 482589000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 482589000.00
RELCHEMQ.NS income_statement (annual, 2025-03-31) — Pretax Income: 36569000.00
RELCHEMQ.NS income_statement (quarterly, 2025-03-31) — Pretax Income: 30290000.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Properties: 0.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
RELCHEMQ.NS cash_flow (annual, 2025-03-31) — Purchase Of Investment: 0.00
RELCHEMQ.NS cash_flow (annual, 2025-03-31) — Purchase Of PPE: -90101000.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Raw Materials: 224687000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Raw Materials: 224687000.00
RELCHEMQ.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 1742350000.00
RELCHEMQ.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 324869000.00
RELCHEMQ.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 146673000.00
RELCHEMQ.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 42233000.00
RELCHEMQ.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 2981000.00
RELCHEMQ.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 2981000.00
RELCHEMQ.NS cash_flow (annual, 2025-03-31) — Repayment Of Debt: -176184000.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Restricted Cash: 1744000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 1744000.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: 976559000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 976559000.00
RELCHEMQ.NS cash_flow (annual, 2025-03-31) — Sale Of Investment: 394956000.00
RELCHEMQ.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 565000.00
RELCHEMQ.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 238218000.00
RELCHEMQ.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 247197000.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Share Issued: 7543563.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 7543563.00
RELCHEMQ.NS cash_flow (annual, 2025-03-31) — Short Term Debt Issuance: 0.00
RELCHEMQ.NS cash_flow (annual, 2025-03-31) — Short Term Debt Payments: -68580000.00
RELCHEMQ.NS income_statement (annual, 2025-03-31) — Special Income Charges: 10176000.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 1372831000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 1372831000.00
RELCHEMQ.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 1367814000.00
RELCHEMQ.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 1367814000.00
RELCHEMQ.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
RELCHEMQ.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
RELCHEMQ.NS income_statement (annual, 2025-03-31) — Tax Provision: -3883000.00
RELCHEMQ.NS income_statement (quarterly, 2025-03-31) — Tax Provision: 11888000.00